Skip to main content
Jonathan Weiss, MD, Dermatology, Snellville, GA

Jonathan S Weiss MD


Assistant Clinical Professor of Dermatology, Emory University

Join to view full profile
  • 2383 Pate St NSnellville, GA 30078

  • Phone+1 770-972-4845

  • Fax+1 770-972-0358

Dr. Weiss is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganResidency, Dermatology, 1985 - 1988
  • University of Michigan
    University of MichiganInternship, Internal Medicine, 1984 - 1985
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1984

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1987 - 2027
  • MI State Medical License
    MI State Medical License 1986 - 1999
  • MI State Medical License
    MI State Medical License 1986 - 1999
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EMA Mobile, Modernizing Medicine, Inc., 2013-2017
  • CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2013-2017
  • CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2013-2017

Publications & Presentations

PubMed

Press Mentions

  • Ocular Rosacea Underappreciated in Dermatology and Beyond
    Ocular Rosacea Underappreciated in Dermatology and BeyondNovember 4th, 2025
  • FDA Approves Use of up to Three Tubes of Biofrontera Inc.’S Ameluz (Aminolevulinic Acid HCI) Topical Gel, 10% in One Treatment
    FDA Approves Use of up to Three Tubes of Biofrontera Inc.’S Ameluz (Aminolevulinic Acid HCI) Topical Gel, 10% in One TreatmentOctober 7th, 2024
  • Large Cohort Study Finds Isotretinoin Not Associated with IBD
    Large Cohort Study Finds Isotretinoin Not Associated with IBDFebruary 6th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: